Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma

Pazopanib is an oral multi-targeted tyrosine kinase inhibitor and has been approved for metastatic renal cell carcinoma and advanced soft tissue sarcoma. To the best of our knowledge, pazopanib-induced thyrotoxicosis has never been reported. The patient was a 68-year-old woman with renal cell carcin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int Cancer Conf J
Main Authors: Kuribayashi, Sohei, Takao, Tetsuya, Okuda, Yohei, Kawamura, Masataka, Nakano, Kosuke, Kishimoto, Nozomu, Takezawa, Kentaro, Tanigawa, Go, Tsutahara, Koichi, Watanabe, Hirotaka, Umayahara, Yutaka, Yamaguchi, Seiji
Format: Artigo
Sprog:Inglês
Udgivet: Springer Japan 2017
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498272/
https://ncbi.nlm.nih.gov/pubmed/31149484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0288-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker